Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...

Common drug found to dramatically cut odds of gut cancer return - Findings could have global significance and influence treatment guidelines, researchers say ...

This page was updated Sept. 12, 2023, to add data for 2015 through 2019 that was released as part of a court case. For the first time, Americans can see the rise — and fall — of legal opioids entering ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin alfa ...

MoonLake Immunotherapeutics has secured up to $500 million in non-dilutive financing from Hercules Capital, bolstering its cash reserves as it ushers its lead drug for inflammatory diseases through ...